Perbedaan Akbar Indo Makmur Stimec Tbk dan Kimia Farma Tbk: Akbar Indo Makmur Stimec Tbk diperdagangkan di Rp390 (kapitalisasi pasar 86,24 M, volume 24 jam 183 rb), sedangkan Kimia Farma Tbk diperdagangkan di Rp432 (kapitalisasi pasar 2,53 T, volume 24 jam 1,32 jt). Perbedaan utamanya: Kimia Farma Tbk jauh lebih besar — sekitar 29,3× kapitalisasi pasar Akbar Indo Makmur Stimec Tbk, dan Kimia Farma Tbk lebih aktif diperdagangkan (1,32 jt vs 183 rb). Mana yang lebih baik tergantung tujuan investasimu.
| AIMS | KAEF | |
|---|---|---|
Kapitalisasi Pasar | 86,24 M | 2,53 T |
Volume | 183 rb | 1,32 jt |
Lot | 1,83 rb | 13,16 rb |
Perputaran | 71,64 jt | 575,69 jt |
Harga Rata-rata | 391,49 | 437,42 |
Nilai Transaksi | 71,64 jt | 575,69 jt |
Harga Ekuilibrium Indikatif | — | 454 |
Volume Ekuilibrium Indikatif | — | 2,3 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.
Selengkapnya di halaman AIMS →PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Selengkapnya di halaman KAEF →